Back to Search
Start Over
PLK1 and its role in the evolving landscape of KRAS -mutated colorectal cancer.
- Source :
-
Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Aug 31; Vol. 15 (4), pp. 1987-1992. Date of Electronic Publication: 2024 Aug 19. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-24-323/coif). E.X.C participated in clinical trials sponsored by Roche, Merck, GSK, BMS, Jassen, Mirati, Novartis, Gilead, and received honoraria from Merck, AstraZeneca, Ipsen, Roche, Eisai, GSK. The other author has no conflicts of interest to declare.
Details
- Language :
- English
- ISSN :
- 2078-6891
- Volume :
- 15
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of gastrointestinal oncology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39279930
- Full Text :
- https://doi.org/10.21037/jgo-24-323